Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @NaheedKurji
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @NaheedKurji
-
At
@Cyclica we've partnered with Atai Life Sciences to form Entheogenix Biosciences a joint venture that is bringing an avant-garde strategy around psilocybin and other psychedelics to address mental health and neuropsychiatric diseases.#bellletstalk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Taking care of ones
#mentalhealth is as important as taking care of any other health challenge. I’ve gone through my own, and it’s because of the people around me, their willingness to listen, and the unrelenting support that I was able to overcome it.#bellletstalk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naheed Kurji proslijedio/la je Tweet
Today is
#BellLetsTalk
Day! Every year, Bell donates 5¢ to Canadian mental health initiatives for every retweet. Last year, we had 25K retweets. Let’s beat that!Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naheed Kurji proslijedio/la je Tweet
This could be the future of shrooms and other psychedelics.https://bit.ly/2WS7vvR
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naheed Kurji proslijedio/la je Tweet
New technologies continue to pave the path for
#healthcare transformations. This week our CEO,@NaheedKurji was featured in the@TorontoStar on the impact of#precisionmedicine and opportunities for AI to provide insights on a medicine's potential effect. https://www.healthinsight.ca/campaigns/personalized-medicine/ …pic.twitter.com/TaaxN70hQQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naheed Kurji proslijedio/la je Tweet
"Emerging and innovative biotechs will decentralize the
#drugdiscovery pipeline." Our CEO,@NaheedKurji discusses the future of#biotech and#pharma to bring new medicines through the clinic in our most recent feature in the@PharmaVOICE. Read more here:https://www.pharmavoice.com/article/2020-01-pharma-innovation/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naheed Kurji proslijedio/la je Tweet
Today, we are excited to announce the latest addition to our leadership team. Former Director of Applications Science at
@Schrodinger, Melissa Landon joins Cyclica as VP, Chief Strategist. Read the press release here: https://www.businesswire.com/news/home/20200106005584/en/Industry-Shake-Cyclica-Announces-Addition-Dr.-Melissa …pic.twitter.com/nFyqhXBaEq
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naheed Kurji proslijedio/la je Tweet
Just b/c Big Pharma externally sources >50% of their new programs doesn't mean they aren't investing in innovation.. R&D is team sport. W/o them as downstream partners for young biotechs, we'd b unable 2 advance drugs to mkt. They r essential players in the innovation ecosystemhttps://twitter.com/statnews/status/1204370312973959170 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
To build stronger partnerships globally, Cyclica appoints long time pharma R&D leader Vern De Biasi as VP, Global Head of Strategic Partnershipshttps://www.businesswire.com/news/home/20191008005594/en/Build-Stronger-Partnerships-Globally-Cyclica-Appoints-Long …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naheed Kurji proslijedio/la je Tweet
Check out the latest article by our CEO,
@NaheedKurji: What's all the fuss behind polypharmacology and multi-targeted drug design? https://www.linkedin.com/pulse/whats-all-fuss-behind-polypharmacology-multi-targeted-naheed-kurji …#drugdiscovery#polypharmacology@EricTopol@HartungIngo@NatureMedicine@ABuvailo@CBinsights@MaRSDD@startuphealthpic.twitter.com/u2QtRFVegu
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naheed Kurji proslijedio/la je Tweet
Exscientia called as 1 of the few
#AI firms using tech to design multi-targeted drugs in a great piece by@NaheedKurji for@Forbes: https://bit.ly/2nB2Tgj . We agree that the "1 target, 1 drug" paradigm is no longer fit for purpose for an industry lagging behind in productivityHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naheed Kurji proslijedio/la je Tweet
You know what isn't a crucial overall step in drug discovery? Not yet, anyway? Protein structure, as much as it pains me to say that:https://blogs.sciencemag.org/pipeline/archives/2019/09/25/whats-crucial-and-what-isnt …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Designing a highly potent molecule for one target can be limited. What about off-targets, ADME, etc? For many diseases the master key are multi targeted drugs that are designed to be drug like, synthetically accessible, and with PK in mind. https://bit.ly/2mlUc9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naheed Kurji proslijedio/la je Tweet
Thought leadership from
@Cyclica CEO@NaheedKurji on bridging biology, chemistry & computation to design the best medicines: http://ow.ly/tbdp50vxVXb pic.twitter.com/b87NIQl5cY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naheed Kurji proslijedio/la je Tweet
Join
@NaheedKurji in Boston for the@AIinPharma Summit Oct 9 where he'll share@Cyclica's story & some exciting updates. http://ow.ly/Lsy850vC2D8#AI#artificialintelligence#machinelearning#pharmaceuticalspic.twitter.com/C5rtx8HVhJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naheed Kurji proslijedio/la je Tweet
Bridging Biology, Chemistry And Computation To Design The Best Medicines http://bit.ly/2yXQMMM via
@NaheedKurjiHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naheed Kurji proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Naheed Kurji proslijedio/la je Tweet

@NaheedKurji is changing the game of drug discovery. His company@Cyclica's#AI platform analyzes molecules to help scientists design, screen + personalize medicines. http://bit.ly/2O0NNxo#health#healthcare#rarediseaseHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naheed Kurji proslijedio/la je Tweet
Love seeing two
@JLABS companies collaborate to advance healthcare! Congratulations to@Cyclica and Rosetta!https://twitter.com/researchuoft/status/1154063880114647049 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Naheed Kurji proslijedio/la je Tweet
#UofT’s@stagljar & biotechnology company@Cyclica have launched a partnership to advance treatment of drug-resistant lung cancer http://bit.ly/30W8yfc pic.twitter.com/SFYy2m9M6E
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.